BioLert Gets Epilepsy Grant

The American Epilepsy Research Foundation (ERF) has awarded BioLert Ltd. the developer of Epilert a grant of $130,000 to assist in the development of a device for the portable monitoring of epilepsy seizures by patients, reports BioLert CEO Amos Shaham.

The EpiLert Seizure Alert Device comprises a bracelet that automatically sends an alert signal to caregivers when a patient suffers an epileptic seizure. By immediately alerting caregivers of a seizure, the EpiLert can save lives, or prevent severe brain damage, in patients suffering prolonged attacks that require medical intervention. The EpiLert enables patients to lead normal lives and provides peace-of-mind for family members, especially the parents of child patients, who can be assured that their children are being monitored around-the-clock.

The Epilepsy Research Foundation was created through a partnership between the Epilepsy Foundation, the Epilepsy Therapy Development Project (formerly The Epilepsy Project) and Finding a Cure for Epilepsy and Seizures (FACES). The mission of the Epilepsy Research Foundation is to fund new research avenues seeking a cure for epilepsy and to support the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient.

Written by

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam libero diam, elementum eget porttitor at, tincidunt at nulla.